Abstract:Objective:The present work aimed to assess reoxygenation and tumor inhibition during fractionated radiotherapy (FRT) in murine tumors using(18)F-fluoromisonidazole (F-18-FMISO) and(18)F-fluorothymidine (F-18-FLT) based micro positron emission tomography/computed tomography (PET/CT). Materials and Methods:A nude mouse xenograft model was established with the head and neck squamous carcinoma cell (FaDu), followed by administration of FRT. Imaging was carried out with both(18)F-FMISO and(18)F-FLT PET/CT, prior to FRT (Pre-FRT, 0 Gy), during FRT (Inter-FRT, 21 Gy), and after FRT (Post-FRT, 40 Gy). The maximum standardized uptake (SUVmax) and tumor-to-normal muscle ratio (TNR) were determined in regions of interest (ROIs) in(18)F-FMISO and(18)F-FLT PET/CT images. Then, hypoxic (HV) and proliferative tumor (PTV) volumes obtained by PET/CT were analyzed. Immunohistochemistry was performed to analyze the changes of hypoxia-inducible factor- (HIF)-1 alpha, carbonic anhydrase 9 (CAIX), Ki67 and proliferating cell nuclear antigen (PCNA). Associations of the levels of these biomarkers with PET/CT parameters were analyzed. Results:F-18-FMISO PET/CT demonstrated markedly elevated reduction rates of SUVmax (30.3 vs. 14.5%,p= 0.012), TNR (27.9 vs. 18.3%,p= 0.032) and HV (85.0 vs. 71.4%,p= 0.047) from Pre-FRT to Inter-FRT compared with values from Inter-FRT to Post-FRT. Meanwhile, PTV reduction rate in(18)F-FLT PET/CT from Pre-FRT to Inter-FRT was significantly decreased compared with that from Inter-FRT to Post-FRT (21.2 vs. 82.7%,p= 0.012). Tumor HIF-1 alpha, CAIX, Ki67, and PCNA amounts were continuously down-regulated during radiotherapy. TNR (FMISO) showed significant correlations with HIF-1 alpha (r= 0.692,p= 0.015) and CAIX (r= 0.801,p= 0.006) amounts in xenografts, while associations of SUVmax (FMISO) with hypoxia markers were weak (r= 0.418,p= 0.041 andr= 0.389,p= 0.037, respectively). SUVmax (FLT) was significantly correlated with Ki67 (r= 0.792,p= 0.003) and PCNA (r= 0.837,p= 0.004). Conclusions:Tumor reoxygenation occurs early during radiotherapy, while inhibition of cell proliferation by tumoricidal effects mainly takes place gradually with the course of radiotherapy.F-18-FMISO and(18)F-FLT PET/CT are sensitive and non-invasive tools for the monitoring of tumor reoxygenation and proliferation during radiotherapy.

Dual-Tracer Assessment of Dynamic Changes in Reoxygenation and Proliferation Decrease During Fractionated Radiotherapy in Murine Tumors.

18F-HX4/18F-FMISO-based micro PET for imaging of tumor hypoxia and radiotherapy-associated changes in mice

18F-FDG PET/CT for the Early Prediction of the Response Rate and Survival of Patients with Recurrent or Metastatic Breast Cancer.

Spatial Concordance of Tumor Proliferation and Accelerated Repopulation from Pathologic Images to 18F-FLT PET Images.

Spatial Concordance of Tumor Proliferation and Accelerated Repopulation from Pathologic Images to 3'-[18F]Fluoro-3'-Deoxythymidine PET Images: a Basic Study Guided for PET-Based Radiotherapy Dose Painting

In-vivo Comparison of 18F-FLT Uptake, CT Number, Tumor Volume in Evaluation of Repopulation During Radiotherapy for Lung Cancer.

Comparison of Noninvasive Hypoxia Imaging with 18F-Fluoroerythronitroimidazole and 18F-Fluoromisonidazole Pet/Ct in Lung Cancer: A Pilot Clinical Study.

Early Response Monitoring Following Radiation Therapy by Using [18F]FDG and [11c]acetate PET in Prostate Cancer Xenograft Model with Metabolomics Corroboration

Monitoring Tumor Hypoxia Using F-18-Fmiso Pet And Pharmacokinetics Modeling After Photodynamic Therapy

Ex-vivo biodistribution and micro-PET/CT imaging of 18F-FDG, 18F-FLT, 18F-FMISO, and 18F-AlF-NOTA-PRGD2 in a prostate tumor-bearing nude mouse model.

Monitoring Mitochondrial Complex-I Activity Using Novel PET Probe 18F-BCPP-EF Allows Early Detection of Radiotherapy Effect in Murine Squamous Cell Carcinoma

Micro PET imaging of 18F-Fluoromisonidazole in an MDA-MB-231 triple negative human breast cancer xenograft model

Comparison of 18F-FES, 18F-FDG, and 18F-FMISO PET Imaging Probes for Early Prediction and Monitoring of Response to Endocrine Therapy in a Mouse Xenograft Model of ER-Positive Breast Cancer.

18F-fluoroerythronitroimidazole versus 18F-ﬂuoromisonidazole PET/CT in the noninvasive hypoxia imaging of lung cancer: a randomized controlled trial

Biodistribution and PET imaging of ~(18)F-fluoromisonidazole in murine model of lung carcinoma

Monitoring Tumor Hypoxia Using 18 F-FMISO PET and Pharmacokinetics Modeling after Photodynamic Therapy

Dynamic Observation of the Radiosensitive Effect of Irisquinone on Rabbit Vx2 Lung Transplant Tumors by Using Fluorine-18-Deoxyglucose Positron Emission Tomography/Computed Tomography

Role of FLT-PET/CT in Monitoring Early Responses of Colorectal Cancer to Radiotherapy in Animals

A Comparative Study Of Noninvasive Hypoxia Imaging With F-18-Fluoroerythronitroimidazole And F-18-Fluoromisonidazole Pet/Ct In Patients With Lung Cancer

Monitoring the Early Biologic Response of Esophageal Carcinoma after Irradiation with 18F-FLT: an In-Vitro and In-Vivo Study.

A Comparative Study of Noninvasive Hypoxia Imaging with 18F-Fluoroerythronitroimidazole and 18F-Fluoromisonidazole PET/CT in Patients with Lung Cancer